ID: h-beb59dfd
Hypothesis
Circadian Rhythm Amplification to Restore Network Oscillation Synchronization
Circadian Rhythm Amplification to Restore Network Oscillation Synchronization.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 5 support✗ 5 oppose
🧪 Overview
Circadian Rhythm Amplification to Restore Network Oscillation Synchronization
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Circadian Rhythm<br/>Amplification Intervention"]
B["SCN Pacemaking Neurons<br/>Oscillation Strength"]
C["Network Oscillation<br/>Synchronization Restored"]
D["BMAL1/CLOCK<br/>Clock Gene Activation"]
E["Sleep-Wake Cycle<br/>Normalization"]
F["Neurodegeneration<br/>Progression Slowed"]
G["Circadian Amplification<br/>as Network Stabilizer"]
A --> B
B --> C
C --> D
D --> E
E --> F
G -.->|"sustains"| B
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style F fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix5 supports5 contradicts
Supports
Circadian dysfunction is bidirectional with AD - disruption increases risk, pathology disrupts rhythms
Supports
Glymphatic Aβ clearance occurs primarily during sleep and is activity-dependent
Supports
Hub regions show high metabolic activity and are preferentially affected by circadian disruption
Supports
Suvorexant (orexin antagonist) showed modest amyloid biomarker improvement in Phase 2
Contradicts
RORα agonist SR1078 developed for cancer - no brain penetration data, no AD validation
Contradicts
Melatonin and sleep hygiene interventions failed to demonstrate disease-modifying effects
Contradicts
Circadian disruption may be biomarker, not cause - downstream of AD pathology
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — CIRCADIAN
No curated PDB or AlphaFold mapping for CIRCADIAN yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for Circadian Rhythm Amplification.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↗
Rising
7d Momentum
▲ 1.6%
Volatility
Low
0.0157
Events (7d)
3
Price History
▲34.0%💾 Resource Usage
LLM Tokens
47,826
$0.1435
Total Cost
$0.1435
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we stratify participants based on circadian amplitude quartiles (bottom 25% vs top 25%) using 14-day ambulatory actigraphy monitoring, THEN the low circadian amplitude subgroup will exhibit reduced | Low circadian amplitude group shows ≥25% lower beta-band coherence (frontal-to-temporal) and ≥30% lower theta-gamma coupling index relative to high amplitude gr | — no observation — | pending | 0.45 |
| IF we pharmacologically amplify circadian rhythm amplitude using timed melatonin receptor agonists (e.g., tasimelteon) combined with morning bright light therapy in adults aged 55-75 with documented n | Mean PLV increase of ≥0.15 in the 0.1-0.4 Hz frequency band measured via high-density EEG during working memory tasks | — no observation — | pending | 0.50 |
🔮 Falsifiable Predictions (2)
pendingconf 50%
IF we pharmacologically amplify circadian rhythm amplitude using timed melatonin receptor agonists (e.g., tasimelteon) combined with morning bright light therapy in adults aged 55-75 with documented network oscillation desynchronization, THEN we will observe a statistically significant increase in g
Predicted outcome: Mean PLV increase of ≥0.15 in the 0.1-0.4 Hz frequency band measured via high-density EEG during working memory tasks
Falsification: No significant difference in PLV between intervention and sham groups (p > 0.05, Cohen's d < 0.3), or PLV change < 0.08 in intervention arm
pendingconf 45%
IF we stratify participants based on circadian amplitude quartiles (bottom 25% vs top 25%) using 14-day ambulatory actigraphy monitoring, THEN the low circadian amplitude subgroup will exhibit reduced inter-regional beta band (13-30 Hz) coherence during REM sleep and reduced theta-gamma coupling dur
Predicted outcome: Low circadian amplitude group shows ≥25% lower beta-band coherence (frontal-to-temporal) and ≥30% lower theta-gamma coupling index relative to high am
Falsification: No significant between-group difference in beta-band coherence (t < 2.0, p > 0.05) or theta-gamma coupling (difference < 10%), OR correlation between circadian amplitude and network metrics r < 0.2
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.